Table 1 Meta-analysis of Prevalence in Sub-groups
Variable | HBV | HCV | HBV-HCV | |||
|---|---|---|---|---|---|---|
Prevalence,% | 95%CI | Prevalence,% | 95%CI | Prevalence,% | 95%CI | |
Study Period | ||||||
Before 2010 | 13.4 | (11.6,15.4) | 31.7 | (24.8,39.2) | 3.6 | (2.3,5.3) |
2010 ~ 2019 | 14.7 | (11.5,18.1) | 8.5 | (5.4,12.3) | 3.5 | (0.9,7.7) |
Study design | ||||||
Retrospective | 13.6 | (11.8,15.5) | 23.4 | (17.8,29.5) | 5.0 | (3.2,7.2) |
Cross-sectional | 14.2 | (11.9,16.6) | 30.2 | (16.2,46.4) | 3.3 | (2,4.8) |
Gender | ||||||
Male (≥80%) | 13 | (10.8,15.4) | 21 | (10.4,34) | 4.0 | (2.2,6.4) |
Others | 13.9 | (11.9,16) | 24.9 | (18.6,31.8) | 3.1 | (1.6,5.1) |
Study Quality | ||||||
High (Score ≥ 3) | 13.5 | (11.8,15.3) | 21.3 | (15.1,28.3) | 3.6 | (2.1,5.4) |
Low | 14.4 | (10.6,18.6) | 30.8 | (20.6,42) | 3.3 | (1.7,5.4) |
Mean Age | ||||||
≤ 40 | 12.3 | (10.3,14.4) | 31.1 | (21.9,41.1) | 4.1 | (2.4,6.3) |
> 40 | 16.2 | (14.1,18.4) | 12.2 | (3.5,25.2) | 1.5 | (0.7,2.6) |
Geographic region | ||||||
North China | 13.1 | (8.1,19.2) | 28.8 | (12.0,49.5) | 3.0 | (2.1,4.1) |
East China | 14.3 | (11.2,17.6) | 19.5 | (10.1,31.0) | 1.9 | (0.7,3.7) |
South China | 16.7 | (13.1,20.6) | 26.3 | (11.1,45.0) | 4.8 | (1.0,11.0) |
Central China | 15.4 | (11.4,19.8) | 21.3 | (11.5,33.1) | 3.9 | (1.0,8.5) |
Northwest China | 10.2 | (9.2,11.2) | 26.2 | (16.6,37.0) | 2.8 | (0.8,6.0) |
Southwest China | 13.1 | (10.6,15.9) | 16.7 | (6.5,30.5) | 2.0 | (0.4,4.8) |
Multi-regions | 10.0 | (6.8,13.9) | 46.2 | (25.0,68.2) | 6.8 | (3.8,10.5) |